Back to Search
Start Over
The effect of induction chemotherapy on tumor volume and organ-at-risk doses in patients with locally advanced oropharyngeal cancer
- Source :
- Doornaert, P, Dahele, M R, Verbakel, W F A R, Bohoudi, O, Slotman, B J & Langendijk, J A 2013, ' The effect of induction chemotherapy on tumor volume and organ-at-risk doses in patients with locally advanced oropharyngeal cancer ', Radiotherapy and Oncology, vol. 109, no. 2, pp. 269-274 . https://doi.org/10.1016/j.radonc.2013.07.016, Radiotherapy and Oncology, 109(2), 269-274. Elsevier Ireland Ltd, Radiotherapy and Oncology, 109(2), 269-274. ELSEVIER IRELAND LTD
- Publication Year :
- 2013
- Publisher :
- Elsevier BV, 2013.
-
Abstract
- Background and purpose: To retrospectively report changes in gross tumor volume (GTV) and organ-at-risk (OAR) doses after induction chemotherapy (IC) in oropharyngeal cancer using different contouring strategies.Materials and methods: GTV and OARs were delineated on pre- and post-IC planning CT. Two post-IC GTV contours were made: (I) a 'consensus set' using published guidelines (GTV(consensus)). and (2) 'visible set', delineating only visible post-IC GTV (GTV(visible)). Pre-IC interactively optimized volumetric modulated arc therapy plans were generated. The pre-IC planning constraints served as the starting point for both post-IC plans. Results reflect pooled data from all 10 patients.Results: Mean reduction in volume post-IC was 24% and 47% for consensus and visible primary tumor and 57% and 60% for consensus and visible nodes. Compared to pre-IC plans, average mean OAR dose for post-IC GTV(consensus) plans was significantly lower for CL parotid. For GTV(visible) plans both parotids, upper/lower larynx, inferior pharyngeal constrictor and cricopharyngeal muscles were significantly lower. However reductions compared with post-IC GTV(consensus) plans were modest (1.6/1.5/1.2/3.7/5.9/2.6 Gy, respectively).Conclusion: IC in patients with oropharyngeal carcinoma results in substantial reductions in GTVs. If post-IC GTVs are used, which is contrary to current consensus, statistically significant but relatively small OAR dose reductions are observed. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
- Subjects :
- Organs at Risk
Oropharynx cancer
Oncology
Larynx
medicine.medical_specialty
ADVANCED HEAD
Xerostomia
CISPLATIN
NECK-CANCER
Internal medicine
CONCURRENT CHEMORADIOTHERAPY
medicine
Humans
Radiology, Nuclear Medicine and imaging
In patient
Retrospective Studies
DOCETAXEL
Contouring
business.industry
Radiotherapy Planning, Computer-Assisted
Cancer
Induction chemotherapy
Radiotherapy Dosage
Organ-at-risk dose
Hematology
medicine.disease
Primary tumor
FLUOROURACIL
Tumor Burden
INTENSITY-MODULATED RADIOTHERAPY
DELINEATION
Oropharyngeal Neoplasms
medicine.anatomical_structure
Volumetric change
Docetaxel
Oropharyngeal Carcinoma
SQUAMOUS-CELL CARCINOMA
Radiology
SEQUENTIAL CHEMORADIOTHERAPY
business
medicine.drug
Subjects
Details
- ISSN :
- 01678140
- Volume :
- 109
- Database :
- OpenAIRE
- Journal :
- Radiotherapy and Oncology
- Accession number :
- edsair.doi.dedup.....31557bdd1583e529bccf1ccf59803862